Prospective study of plasma urate and risk of Parkinson disease in men and women

Neurology
Xiang GaoA Ascherio

Abstract

To examine whether higher plasma urate concentrations are associated with a lower risk of developing Parkinson disease (PD) and whether there is a sex difference in the potential urate-PD relationship. We conducted a nested case-control study based on 90,214 participants of 3 ongoing US cohorts. We identified 388 new PD cases (202 men and 186 women) since blood collection, which were then matched to 1,267 controls. PD cases were confirmed by medical record review. Conditional logistic regression estimated relative risks (RRs) and 95% confidence intervals (95% CIs), after adjustment for age, smoking, caffeine intake, plasma concentrations of cholesterol and ferritin, and other covariates. We also conducted a meta-analysis to combine our study with 3 previously published prospective studies on urate and PD risk. In the present nested case-control study, the multivariate-adjusted RRs of PD comparing extreme quartiles of urate were 0.63 (95% CI 0.35, 1.10; ptrend = 0.049) in men and 1.04 (95% CI 0.61, 1.78; ptrend = 0.44) in women (pheterogeneity = 0.001). In the meta-analysis, the pooled RRs comparing 2 extreme quartiles of urate were 0.63 (95% CI 0.42, 0.95) in men and 0.89 (95% CI 0.57, 1.40) in women. We observed that men, but ...Continue Reading

References

May 1, 1986·The Biochemical Journal·K J DaviesP Hochstein
Sep 1, 1996·American Journal of Epidemiology·J W DavisD M Morens
Sep 27, 2002·QJM : Monthly Journal of the Association of Physicians·W S Waring
Mar 25, 2005·Free Radical Research·Andrew J GhioJohn R Hoidal
Oct 22, 2005·Annals of Neurology·Lonneke M L de LauMonique M B Breteler
Feb 3, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Giancarlo LogroscinoAlberto Ascherio
Jun 28, 2006·Annals of Neurology·Alberto AscherioMichael J Thun
Aug 15, 2006·American Journal of Epidemiology·Lonneke M L de LauMonique M B Breteler
Jun 23, 2007·American Journal of Epidemiology·M G WeisskopfA Ascherio
Sep 1, 2007·Neurology·Kelly Claire SimonAlberto Ascherio
Oct 24, 2007·Neurology·Alvaro AlonsoMiguel A Hernán
Mar 11, 2008·American Journal of Epidemiology·Xiang GaoAlberto Ascherio
Apr 17, 2008·Archives of Neurology·Michael A SchwarzschildJohn Ondrasik
Nov 1, 2008·Arthritis and Rheumatism·Mary De VeraHyon Choi
Mar 21, 2009·American Journal of Epidemiology·Honglei ChenXuemei Huang
Oct 14, 2009·Archives of Neurology·Alberto AscherioUNKNOWN Parkinson Study Group DATATOP Investigators
Jul 14, 2010·Archives of Neurology·Rodolfo SavicaJ Eric Ahlskog
Aug 5, 2010·American Journal of Epidemiology·Eilis J O'ReillyAlberto Ascherio
Mar 4, 2011·Neurology·Xiang GaoAlberto Ascherio
May 4, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Michael A SchwarzschildUNKNOWN Parkinson Study Group PRECEPT Investigators
Mar 13, 2012·Neuroscience Letters·Hai-nan ZhangBei-sha Tang
May 15, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S JesúsP Mir
May 15, 2012·Current Neurology and Neuroscience Reports·Xiqun ChenMichael A Schwarzschild
Dec 19, 2012·Proceedings of the National Academy of Sciences of the United States of America·Xiqun ChenMichael A Schwarzschild
Mar 5, 2013·European Journal of Epidemiology·Eva SchernhammerBeate Ritz
Mar 8, 2013·Neuro-degenerative Diseases·Nikolaus R McFarlandMichael A Schwarzschild
Mar 29, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Reinaldo Uribe-San MartínCarlos Juri
May 29, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Isabel González-AramburuJon Infante
Sep 27, 2014·Annals of Neurology·Kelly Claire SimonUNKNOWN Parkinson Study Group

❮ Previous
Next ❯

Citations

Oct 19, 2016·Lancet Neurology·Alberto Ascherio, Michael A Schwarzschild
Oct 28, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Katherine C HughesAlberto Ascherio
Jun 2, 2017·Physical Chemistry Chemical Physics : PCCP·Leonardo Muñoz-RugelesJuan Raúl Alvarez-Idaboy
Dec 27, 2017·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Éilis J O'ReillyAlberto Ascherio
Aug 2, 2018·CNS Drugs·Dilan Athauda, Thomas Foltynie
Jul 18, 2018·Annals of Neurology·Camilla J KobyleckiShoaib Afzal
Mar 31, 2017·Journal of the American Heart Association·Chongke ZhongYonghong Zhang
Feb 15, 2019·Annals of Neurology·Rachit BakshiMichael A Schwarzschild
Jan 18, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Connie Marras, Jose A Obeso
Aug 15, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Sebastian HeinzelUNKNOWN MDS Task Force on the Definition of Parkinson's Disease
Nov 21, 2017·Journal of Parkinson's Disease·Honglei Chen
Nov 13, 2019·Annals of Clinical and Translational Neurology·Yun ShenXiang Gao
Jan 5, 2020·Nature Reviews. Neurology·Sara MeoniElena Moro
Jun 10, 2017·Neurology·Katherine C HughesAlberto Ascherio
Sep 6, 2019·Neurology·Michael A SchwarzschildUNKNOWN Parkinson Study Group SURE-PD Investigators
Sep 8, 2017·Neurology·Honglei ChenUNKNOWN Health ABC Study
Jan 30, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·K BaikP H Lee
May 23, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Jin Ho JungPhil Hyu Lee
Jul 10, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Ariel Fangting YingLouis C S Tan
Nov 24, 2016·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Lijun WangQi Wan
Jul 7, 2017·Translational Neurodegeneration·Chaoran MaXiang Gao
Aug 14, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·E A KatuninaE I Gaisenuk
May 28, 2020·Frontiers in Neurology·Eldbjørg Hustad, Jan O Aasly
Jul 4, 2017·Acta Neurologica Scandinavica·D GeorgievG-M Hariz
Jan 6, 2017·Journal of Neurology·Marina PicilloMaria Teresa Pellecchia
May 11, 2017·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P YinP Tang
Aug 1, 2018·Nutrients·Claudio TanaTiziana Meschi
Oct 27, 2018·Movement Disorders Clinical Practice·Masoom M AbbasLouis C S Tan
May 24, 2020·Journal of Parkinson's Disease·Daniel J van WamelenK Ray Chaudhuri
Sep 16, 2020·Nutrients·Erika OlssonSusanna C Larsson
Oct 24, 2018·Annals of Clinical and Translational Neurology·Chaoran MaXiang Gao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Epidemiology
M G WeisskopfA Ascherio
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Howard D SessoJ Michael Gaziano
© 2022 Meta ULC. All rights reserved